Market Research Logo

Childhood Absence Epilepsy Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Childhood Absence Epilepsy Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Childhood absence epilepsy diagnosis revolves around identifying symptoms and categorizing the epilepsy type based on those symptoms. Diagnostic methods and techniques for childhood absence epilepsy include electroencephalogram (EEG)/video telemetry, magnetic resonance imaging (MRI scans), and blood tests. In electroencephalogram (EEG)/video telemetry, electrical signals from brain are recorded in a computer by asking the patient to hyperventilate for 3 to 5 minutes, which triggers an absence seizure. The EEG then shows spikes and wave discharges at 3 Hz (cycles per second) that are generalized in nature (similar on both sides of the brain). Structural causes behind epilepsy can be understood with the help of MRI scans (as some patients suffering from epilepsy due to brain damage can be found by a MRI scan). Blood tests may be required to diagnose any medical conditions, which may be the reason behind epilepsy.

Market Dynamics

Key players in the market are focused on the development of new drugs for the treatment of childhood absence epilepsy. Factors such as increasing prevalence of the disease, increasing accessibility of medications, and presence of drugs in pipeline for childhood absence epilepsy treatment (Insys therapeutics and Cavion, Inc.) are expected to boost the global childhood absence epilepsy treatment market growth. Product launches by generic manufacturers in the U.S. as well as globally is expected to support growth of the market. For instance, Dr. Reddy’s Laboratories launched generic lamotrigine orally disintegrating tablets in the U.S. in 2016. Moreover, a number of manufacturers such as Insys Therapeutics (Cannabidiol) and Cavion, Inc. (CX-8998) have drugs in phase II stage in clinical trials and these therapies are expected to be launched over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of childhood absence epilepsy treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global childhood absence epilepsy treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include Cavion, Inc., Pfizer, Inc., GlaxoSmithKline Plc, Insys Therapeutics, Inc., AbbVie, Inc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
  • The global childhood absence epilepsy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the childhood absence epilepsy treatment market
Detailed Segmentation:
  • Global Childhood Absence Epilepsy Treatment Market, By Drug:
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • Global Childhood Absence Epilepsy Treatment Market, By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • Global Childhood Absence Epilepsy Treatment Market, By Region:
  • North America
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug
  • Ethosuximide
  • Valproate
  • Lamotrigine
  • Phase 2 Drugs
  • Cannabidiol Oral Solution
  • CX-8998
  • By Disease Type:
  • Typical Absence Seizures
  • Atypical Absence Seizures
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Cavion, Inc. *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Pfizer, Inc.
  • GlaxoSmithKline Plc
  • Insys Therapeutics, Inc.
  • AbbVie, Inc.
  • Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug
Market Snippet, By Disease Type
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
About Childhood Absence Epilepsy
Diagnosis of Childhood Absence Epilepsy
Treatment Approaches
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Pipeline Analysis
4. Global Childhood Absence Epilepsy Treatment Market, By Drug, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Ethosuximide
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Valproate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Lamotrigine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Phase 2 Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Cannabidiol Oral Solution
CX-8998
5. Global Childhood Absence Epilepsy Treatment Market, By Disease Type, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Typical Absence Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Atypical Absence Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
6. Global Childhood Absence Epilepsy Treatment Market, By Region, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2026
North America
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Drug, 2018–2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
GCC
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Cavion, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Insys Therapeutics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 37 figures on "Childhood Absence Epilepsy Treatment Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report